Global parameters and variables for the model. by Alexandra M. Campbell (3284094)

Subjects:

Estimated parameters for distribution of basal area. by Alexandra M. Campbell (3284094)

Subjects:

Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Variables of patch located at coordinates . by Alexandra M. Campbell (3284094)

Subjects:

MRSP Tree Host Data. by Alexandra M. Campbell (3284094)

Subjects:

<i>Tillandsia utriculata</i> death rate data by size class. by Alexandra M. Campbell (3284094)

Subjects:

Histograms of (A) distance measured in meters to nearest neighboring tree given bin widths of 2 m (<i>n</i> = 44), and (B) basal areas of all sampled trees (<i>n</i> = 58; bin widt... by Alexandra M. Campbell (3284094)

Subjects:

Parameter sets generated through Latin hypercube sampling. by Alexandra M. Campbell (3284094)

Subjects:

Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Subjects:

Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

The mean scores of epidermis and dermis healing processes in burned rats after 10 and 21 days treatment with silver sulfadiazine 1% (silver), opium 0.05% (OP 0.05%), opium 0.5% (OP... by Omid Mehrpour (9385929)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Mean AIV-H9N2 shedding titer (Log₁₀) in oropharyngeal swabs. by Oumayma Arbani (21001472)

Subjects: